Trapelo™ assures that each lab order is precisely determined by the characteristics of each patient’s tumor, and is supported by up-to-date clinical evidence, eliminating the need for prior authorization for molecular medicine. This reduces unnecessary costs while expediting and streamlining the process.  

 

  • Comprehensive: Effective for all solid tumors 

  • Connected: Integrated with providers and labs

  • Convenient: Accessible from within your own portal

‚Äč

PRECISION CARE MANAGEMENT FOR PAYORS 

“For the majority of payers, cost has risen to become the most important factor influencing biomarker coverage, followed closely by clinical validity and utility.”

– The Precision Oncology Annual Trend Report, 2016

Contact us to schedule a demo

PHONE  617.250.7572

FAX  888.972.5991

EMAIL info@interventioninsights.com

800 District Ave, Suite 310
Burlington, MA 01803

Google Map »

icon-linkedin.png
TwitterIcon_Bird_Only2.png
YouTube_Icon_Only_Orange_Trans.png

Copyright 2019 Intervention Insights. All rights reserved. Privacy Policy